ADCYAP1 and dilated cardiomyopathy: Among others, PACAP has a potential biomarker value in dilatative cardiomyopathy, cardiac infarct, Parkinson’s disease, migraine, polytrauma and chronic rhinosinusitis (127, 137–141).